Cytokinetics (CYTK) Tops Q1 EPS by 1c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $80.01 +1.06%
EPS Growth %: -46.4%
Financial Fact:
Net loss: 31.89M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -46.4%
Financial Fact:
Net loss: 31.89M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q1 EPS of ($1.36), $0.01 better than the analyst estimate of ($1.37). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $3.6 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
- Pacific Booker Minerals Inc. Adopts Advance Notice Policy for Director Elections
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
